Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus monotherapy in nephrotic idiopathic membranous nephropathy
ChiCTR1900021314Phase 4Completed
- Sponsor
- Tianjin Hospital
- Start
- Jan 2013
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tacrolimus in idiopathic membranous glomerulonephritis (IMG), sponsored by Tianjin Hospital. Primary endpoint: Remission rate. Started Jan 2013; status: completed.
02
Drugs
tacrolimus
03
Conditions
idiopathic membranous glomerulonephritis (IMG)
Beyond the preview
Go deeper on ChiCTR1900021314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021314.